{"pub": "dailymail", "url": "https://dailymail.co.uk/wires/reuters/article-7550893/GSK-recalls-popular-heartburn-medicine-Zantac--U-K-medicines-watchdog.html", "downloaded_at": "2019-10-08 16:00:06.165790+00:00", "title": "GSK recalls popular heartburn medicine Zantac - U.K....", "language": "en", "text": "Oct 8 (Reuters) - GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a \"precautionary measure\" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.\n\nGSK is recalling all unexpired stock of Zantac, also sold generically as ranitidine, from pharmacies as a precaution due to possible contamination with an impurity NDMA, which has genotoxic and carcinogenic potential, the Medicines and Healthcare products Regulatory Agency (MHRA) said https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-zantac-injection-50mg-2ml-zantac-syrup-150mg-10ml-zantac-tablets-150mg-zantac-tablets-300mg-el-19-a-24. (Reporting by Justin George Varghese in Bengaluru; editing by Bill Berkrot)", "description": "Oct 8 (Reuters) - GlaxoSmithKline Plc is recalling  its heartburn medicine Zantac as a", "authors": [], "top_image": "https://i.dailymail.co.uk/i/pix/m_logo_636x382px.png", "published_at": "2019-10-08"}